{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.3616.200.110.102.4019",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2020-12-17T01:00:39.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.4019",
  "version": "20201217",
  "name": "COVID19 ICD10PCS Value Set for Administration of Tocilizumab",
  "status": "active",
  "date": "2020-12-17T01:00:39-05:00",
  "publisher": "Clinical Architecture",
  "compose": {
    "include": [
      {
        "system": "http://www.icd10data.com/icd10pcs",
        "version": "2022",
        "concept": [
          {
            "code": "XW033H5",
            "display": "Introduction of Tocilizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5"
          },
          {
            "code": "XW043H5",
            "display": "Introduction of Tocilizumab into Central Vein, Percutaneous Approach, New Technology Group 5"
          }
        ]
      }
    ]
  }
}